TrialCroatian medical journal2021

Remifentanil target-controlled infusion with intranasal dexmedetomidine for vitreoretinal procedures: a randomized controlled trial.

Iztok Potočnik et al.PubMed ↗Full text ↗

No numbers read from the abstract.